论文部分内容阅读
[目的]观察IZL-2003免疫治疗系统对恶性肿瘤患者放化疗后骨髓抑制的近期疗效和生存质量的影响。[方法]选择长沙市第一医院2007年11月至2010年10月恶性肿瘤患者放化疗后骨髓抑制患者160例,其中治疗组(IZL-2003免疫治疗系统穴位辐照)86例、对照组(常规给予维生素C、维生素B6)74例,7d为1个疗程,治疗2个疗程。[结果]治疗组外周血白细胞提升总有效率(76.7%)明显高于对照组(48.6%),(P<0.05);治疗组患者KPS评分、食欲及睡眠改善有效率分别为55.8%、68.6%、37.2%,显著高于对照组的36.5%、48.6%、14.8%(P<0.05);治疗组中4种不同肿瘤白细胞、KPS评分、食欲及睡眠改善情况无显著性差异(P>0.05)。[结论]IZL-2003免疫治疗系统可刺激和增强骨髓造血功能,改善患者生存质量。
[Objective] To observe the effect of IZL-2003 immunotherapy system on the short-term efficacy and quality of life of patients with malignant tumor after radiotherapy and chemotherapy. [Method] 160 patients with bone marrow suppression after radiotherapy and chemotherapy of malignant tumor from November 2007 to October 2010 in Changsha First Hospital were enrolled. 86 patients in the treatment group (IZL-2003 immunotherapy system acupoint irradiation), 86 patients in the control group Routine administration of vitamin C, vitamin B6) 74 cases, 7d for a course of treatment, treatment of 2 courses. [Results] The total effective rate of peripheral blood leukocyte enhancement in the treatment group (76.7%) was significantly higher than that in the control group (48.6%) (P <0.05). The KPS score, appetite and sleep improvement rate in the treatment group were 55.8% and 68.6% %, 37.2% respectively, which were significantly higher than that of the control group (36.5%, 48.6%, 14.8%, P <0.05). There was no significant difference in the KPS score, appetite and sleep improvement ). [Conclusion] The IZL-2003 immunotherapy system can stimulate and enhance the hematopoietic function of bone marrow and improve the quality of life of patients.